These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 10699710

  • 1. Solid lipid nanoparticles as drug carriers for topical glucocorticoids.
    Maia CS, Mehnert W, Schäfer-Korting M.
    Int J Pharm; 2000 Mar 10; 196(2):165-7. PubMed ID: 10699710
    [Abstract] [Full Text] [Related]

  • 2. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.
    Gysler A, Kleuser B, Sippl W, Lange K, Korting HC, Höltje HD, Korting HC.
    Pharm Res; 1999 Sep 10; 16(9):1386-91. PubMed ID: 10496654
    [Abstract] [Full Text] [Related]

  • 3. Drug targeting by solid lipid nanoparticles for dermal use.
    Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schäfer-Korting M.
    J Drug Target; 2002 Sep 10; 10(6):489-95. PubMed ID: 12575739
    [Abstract] [Full Text] [Related]

  • 4. Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids.
    Schlupp P, Blaschke T, Kramer KD, Höltje HD, Mehnert W, Schäfer-Korting M.
    Skin Pharmacol Physiol; 2011 Sep 10; 24(4):199-209. PubMed ID: 21346400
    [Abstract] [Full Text] [Related]

  • 5. Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin.
    Haberland A, Santos Maia C, Jores K, Dürrfeld M, Mehnert W, Schimke I, Christ B, Schäfer-Korting M.
    ALTEX; 2003 Sep 10; 20(1):3-9. PubMed ID: 12579349
    [Abstract] [Full Text] [Related]

  • 6. Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.
    Gysler A, Lange K, Korting HC, Schäfer-Korting M.
    Pharm Res; 1997 Jun 10; 14(6):793-7. PubMed ID: 9210199
    [Abstract] [Full Text] [Related]

  • 7. Esterase activity in excised and reconstructed human skin--biotransformation of prednicarbate and the model dye fluorescein diacetate.
    Bätz FM, Klipper W, Korting HC, Henkler F, Landsiedel R, Luch A, von Fritschen U, Weindl G, Schäfer-Korting M.
    Eur J Pharm Biopharm; 2013 Jun 10; 84(2):374-85. PubMed ID: 23201050
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids.
    Lange K, Kleuser B, Gysler A, Bader M, Maia C, Scheidereit C, Korting HC, Schäfer-Korting M.
    Skin Pharmacol Appl Skin Physiol; 2000 Jun 10; 13(2):93-103. PubMed ID: 10754457
    [Abstract] [Full Text] [Related]

  • 11. Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro.
    Lange K, Gysler A, Bader M, Kleuser B, Korting HC, Schäfer-Korting M.
    Pharm Res; 1997 Dec 10; 14(12):1744-9. PubMed ID: 9453063
    [Abstract] [Full Text] [Related]

  • 12. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
    Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, Röder B, Kramer KD, Schäfer-Korting M.
    J Control Release; 2005 Dec 10; 110(1):151-63. PubMed ID: 16297487
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential.
    Ferreira M, Silva E, Barreiros L, Segundo MA, Costa Lima SA, Reis S.
    Int J Pharm; 2016 Oct 15; 512(1):14-21. PubMed ID: 27530292
    [Abstract] [Full Text] [Related]

  • 14. In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use.
    Lombardi Borgia S, Schlupp P, Mehnert W, Schäfer-Korting M.
    Eur J Pharm Biopharm; 2008 Feb 15; 68(2):380-9. PubMed ID: 17574402
    [Abstract] [Full Text] [Related]

  • 15. Design of solid lipid nanoparticles for caffeine topical administration.
    Puglia C, Offerta A, Tirendi GG, Tarico MS, Curreri S, Bonina F, Perrotta RE.
    Drug Deliv; 2016 Feb 15; 23(1):36-40. PubMed ID: 24735249
    [Abstract] [Full Text] [Related]

  • 16. The impact of skin viability on drug metabolism and permeation -- BSA toxicity on primary keratinocytes.
    Haberland A, Schreiber S, Maia CS, Rübbelke MK, Schaller M, Korting HC, Kleuser B, Schimke I, Schäfer-Korting M.
    Toxicol In Vitro; 2006 Apr 15; 20(3):347-54. PubMed ID: 16182510
    [Abstract] [Full Text] [Related]

  • 17. Heptapeptide-loaded solid lipid nanoparticles for cosmetic anti-aging applications.
    Suter F, Schmid D, Wandrey F, Zülli F.
    Eur J Pharm Biopharm; 2016 Nov 15; 108():304-309. PubMed ID: 27343822
    [Abstract] [Full Text] [Related]

  • 18. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin.
    Ridolfi DM, Marcato PD, Justo GZ, Cordi L, Machado D, Durán N.
    Colloids Surf B Biointerfaces; 2012 May 01; 93():36-40. PubMed ID: 22244299
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptake.
    Sivaramakrishnan R, Nakamura C, Mehnert W, Korting HC, Kramer KD, Schäfer-Korting M.
    J Control Release; 2004 Jul 07; 97(3):493-502. PubMed ID: 15212881
    [Abstract] [Full Text] [Related]

  • 20. Increased permeability of reconstructed human epidermis from UVB-irradiated keratinocytes.
    Löwenau LJ, Zoschke C, Brodwolf R, Volz P, Hausmann C, Wattanapitayakul S, Boreham A, Alexiev U, Schäfer-Korting M.
    Eur J Pharm Biopharm; 2017 Jul 07; 116():149-154. PubMed ID: 28034807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.